Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Enhancing Modulation Effects of Baduanjin Through Neuromodulation for Knee OA — Stella

Home/Knee Osteoarthritis/Enhancing Modulation Effects of Baduanjin Through Neuromodulation for Knee OA

View on ClinicalTrials.gov

Recruiting

Back to Knee Osteoarthritis trials

Enhancing Modulation Effects of Baduanjin Through Neuromodulation for Knee OA

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Massachusetts General Hospital, Charlestown, Massachusetts

Key details

Phase

Safety & dosing

Sponsor

Massachusetts General Hospital

Enrollment target

~140 participants

Started

March 2024

Primary completion

March 2028

Age range

45 Years – 75 Years

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.